Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03240211
Title Study of Pembrolizumab Combined With Decitabine and Pralatrexate in PTCL and CTCL
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Owen A. O'Connor
Indications

peripheral T-cell lymphoma

primary cutaneous T-cell non-Hodgkin lymphoma

Therapies

Pembrolizumab + Pralatrexate

Decitabine + Pembrolizumab + Pralatrexate

Decitabine + Pembrolizumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.